GHR and hepatocellular carcinoma: The results of western blotting assay showed that sorafenib stimulated GHR expression in HepG2 and Huh7 cell lines, while other drugs including regorafenib, lenvatinib, and cabozantinib had no effects on GHR expression in HCC cell lines (Figure 1A, 1B).